NEE
42
4
GOOGL
59
5
L
63
3
AES
38
3
LRCX
64
6
EXPE
77
5
ADSK
61
5
CMI
54
3
NTAP
54
4
COST
50
2
MS
72
3
PNR
72
3
BA
52
3
CME
59
3
NWSA
82
6
APH
83
2
RIG
25
2
QCOM
62
13
GS
72
2
AAL
27
7
NEE
42
4
GOOGL
59
5
L
63
3
AES
38
3
LRCX
64
6
EXPE
77
5
ADSK
61
5
CMI
54
3
NTAP
54
4
COST
50
2
MS
72
3
PNR
72
3
BA
52
3
CME
59
3
NWSA
82
6
APH
83
2
RIG
25
2
QCOM
62
13
GS
72
2
AAL
27
7
Financhill
Back

Ionis Pharmaceuticals 10K Form

Sell
44

IONS
Ionis Pharmaceuticals

Last Price:
$32.77
Seasonality Move:
3.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q IONS/Ionis Pharmaceuticals Quarterly
2023-08-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2023-05-03 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-11-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-08-09 10Q IONS/Ionis Pharmaceuticals Quarterly
2022-05-04 10Q IONS/Ionis Pharmaceuticals Quarterly

Receive IONS News And Ratings

See the #1 stock for the next 7 days that we like better than IONS

IONS Financial Statistics

Sales & Book Value

Annual Sales: $705.1M
Cash Flow: $-164M
Price / Cash Flow: 0
Annual Sales: $2.99
Price / Book: 10.97

Profitability

EPS (TTM): -2.99000
Net Income (TTM): $-458M
Gross Margin: $693.9M
Return on Equity: -100.15%
Return on Assets: -15.96%

Ionis Pharmaceuticals Earnings Forecast

Key Ionis Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 35 years for IONS is 98.41%.
  • The Selling, General & Administrative Expenses for IONS have been equal to 37.94% of Gross Profit Margin.
  • The Research & Development expenses have been 127.85% of Revenue.
  • The Net Earning history of IONS is -64.37% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 16 years.

Ionis Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IONS
CUSIP: 462222
Website: ionis.com

Debt

Debt-to-Equity Ratio: 2.63
Current Ratio: 9.66
Quick Ratio: 8.73

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IONS Technical Analysis vs Fundamental Analysis

Sell
44
Ionis Pharmaceuticals (IONS) is a Sell

Is Ionis Pharmaceuticals a Buy or a Sell?